- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Ramsey Today
By the People, for the People
B Group Inc. Increases Stake in ADMA Biologics
Institutional investor now owns over 2.4 million shares of the biotechnology company
Mar. 14, 2026 at 7:07am
Got story updates? Submit your updates here. ›
B Group Inc. has increased its stake in ADMA Biologics Inc. (NASDAQ:ADMA) by 4.1% during the third quarter, according to a recent 13F filing. The institutional investor now owns 2,412,542 shares of the biotechnology company's stock, making it the largest shareholder and accounting for approximately 26.9% of B Group's holdings.
Why it matters
ADMA Biologics is a biopharmaceutical company focused on the development and commercialization of specialty plasma-derived biologics. The increase in B Group's stake suggests the institutional investor sees significant potential in the company's products and pipeline.
The details
According to the 13F filing, B Group Inc. purchased an additional 95,000 shares of ADMA Biologics during the third quarter, bringing its total ownership to 2,412,542 shares. This represents approximately 1.01% of ADMA Biologics' outstanding shares. The investment firm cited the company's growth prospects and product portfolio as reasons for increasing its position.
- B Group Inc. filed the 13F report disclosing the increased stake on March 14, 2026.
- The additional 95,000 shares were purchased during the third quarter of 2025.
The players
B Group Inc.
An institutional investment firm that has increased its stake in ADMA Biologics to become the company's largest shareholder.
ADMA Biologics Inc.
A biopharmaceutical company focused on the development and commercialization of specialty plasma-derived biologics.
The takeaway
The increased stake by B Group Inc. in ADMA Biologics suggests the institutional investor sees significant growth potential in the company's products and pipeline, which could signal positive developments for the biotechnology firm going forward.
